I hear you but try this though
18 million in the bank - EV 58 million, no CR for a year
First sales this FY
Clear runway to UK private market
Clean sweep of management with entirely new team with deep expertise and connections in the radiopharma market
No real advances in treatment of ca pancreas, and this is adjuvant to chemo in any case. Main competitor is EBR
Chance of FDA approval for cholangio, chance of FDA allowing smaller than expected RCT for LAPC
I guess if the company goes from 90k sales this year to, say, 2.5 million next FY (100 doses) what does that mean for the share price?
And one of the people asking questions on the last business update was a Swiss fund manager, so maybe some sprouts of interest.
- Forums
- ASX - By Stock
- Ann: Half Yearly Report and Accounts
I hear you but try this though18 million in the bank - EV 58...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OSL (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $37.84M |
Open | High | Low | Value | Volume |
1.0¢ | 1.0¢ | 1.0¢ | $80.93K | 8.093M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1838260 | 1.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.1¢ | 2964187 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 1838260 | 0.010 |
20 | 11759586 | 0.009 |
8 | 9307600 | 0.008 |
19 | 13641677 | 0.007 |
14 | 13455000 | 0.006 |
Price($) | Vol. | No. |
---|---|---|
0.011 | 2964187 | 7 |
0.012 | 5705600 | 8 |
0.013 | 11056832 | 5 |
0.014 | 6162166 | 9 |
0.015 | 8500000 | 3 |
Last trade - 16.10pm 14/08/2024 (20 minute delay) ? |
Featured News
OSL (ASX) Chart |